about
Artery Tertiary Lymphoid Organs: Powerhouses of Atherosclerosis Immunity.Remodeling of lipid bodies by docosahexaenoic acid in activated microglial cellsPain regulation by non-neuronal cells and inflammation.Potential anti-inflammatory, antioxidant and antimicrobial activities of Sambucus australis.Characterizing the anti-inflammatory and tissue protective actions of a novel Annexin A1 peptide.Maresin conjugates in tissue regeneration biosynthesis enzymes in human macrophages.Hypoxia inducible factors are dispensable for myeloid cell migration into the inflamed mouse eye.Resolution of Acute Inflammation and the Role of Resolvins in Immunity, Thrombosis, and Vascular Biology.A cluster of immunoresolvents links coagulation to innate host defense in human blood.Induction of Innate Immune Memory by Engineered Nanoparticles: A Hypothesis That May Become True.Biomarker-guided clinical development of the first-in-class anti-inflammatory FPR2/ALX agonist ACT-389949.Annexin A1: shifting the balance towards resolution and repair.Hypoxia-inducible factors: key regulators of myeloid cells during inflammation.Beyond pan-B-cell-directed therapy - new avenues and insights into the pathogenesis of SLE.The immune system's role in sepsis progression, resolution, and long-term outcome.Treating inflammation and infection in the 21st century: new hints from decoding resolution mediators and mechanisms.From leukocyte recruitment to resolution of inflammation: the cardinal role of integrins.Structural elucidation and physiologic functions of specialized pro-resolving mediators and their receptors.Resolution of inflammation pathways in preeclampsia-a narrative review.Modulation of innate immunity of patients with Alzheimer's disease by omega-3 fatty acids.The novel lipid mediator PD1n-3 DPA: An overview of the structural elucidation, synthesis, biosynthesis and bioactions.Macrophage-derived IL-10 mediates mucosal repair by epithelial WISP-1 signaling.Specialized Pro-resolving Mediators (SPM) Rescue Infant Mice from Lethal Citrobacter rodentium Infection and Promote Immunity against Re-infection.Resolvin D1 enhances the resolution of lung inflammation caused by long-term Pseudomonas aeruginosa infection.Novel Resolvin D2 Receptor Axis in Infectious Inflammation.Expanding the nematode model system: The molecular basis of inflammation and infection recovery in C. elegans.13-Series resolvins mediate the leukocyte-platelet actions of atorvastatin and pravastatin in inflammatory arthritis.Inflammation and its resolution and the musculoskeletal systemIncreased 15-PGDH expression leads to dysregulated resolution responses in stromal cells from patients with chronic tendinopathy.Resolvin D1 Improves the Resolution of Inflammation via Activating NF-κB p50/p50-Mediated Cyclooxygenase-2 Expression in Acute Respiratory Distress Syndrome.Obesity and Cardiometabolic Defects in Heart Failure Pathology.Endotoxemia shifts neutrophils with TIMP-free gelatinase B/MMP-9 from bone marrow to the periphery and induces systematic upregulation of TIMP-1.Environmental perfluorooctane sulfonate exposure drives T cell activation in bottlenose dolphins.Diabetes and Sepsis: Risk, Recurrence, and Ruination.TNF Tolerance in Monocytes and Macrophages: Characteristics and Molecular Mechanisms.Resolvins suppress tumor growth and enhance cancer therapy.Neutrophil-Particle Interactions in Blood Circulation Drive Particle Clearance and Alter Neutrophil Responses in Acute Inflammation.Proteomic Signature Reveals Modulation of Human Macrophage Polarization and Functions Under Differing Environmental Oxygen Conditions.Neuroinflammation, Mast Cells, and Glia: Dangerous Liaisons.Annexin A1 and specialized proresolving lipid mediators: promoting resolution as a therapeutic strategy in human inflammatory diseases.
P2860
Q28072367-E94E4A9B-4042-4252-B9EC-AF94657C4784Q28395128-6943FB25-55B0-4B4E-8C89-3EFA3CD7A67FQ33846188-A67EBD83-EF15-421A-904A-3FE8653A3881Q36271915-90131CA5-A854-447B-AE79-B10047DCB67DQ36346110-2CA0F91B-8281-419C-BBA7-647D68215E61Q37379884-BB9079A5-6F72-4CDC-9E17-BBA5FA97681FQ37599358-3493E93A-53FA-42C1-B9B6-EA011E06AFE8Q37603197-D3752F94-2555-4336-B2F8-EF4E38E67DE1Q38647952-0F72157F-0ADF-45F2-8053-E4D0BF5AB4E2Q38659727-88F838A3-B6EE-40BB-9AA4-6CC0B045548EQ38812508-EFA11240-4AAD-45FF-81EC-C577C88332C4Q38846007-33FBEE93-F7AB-4868-98FA-1422E2610714Q38947313-0F447C38-9654-4CE7-B2F2-DE0FE59D882FQ38979169-02D71BE2-922F-408A-B767-D7742FE12F2DQ38991057-24944CA4-1A04-46CE-A566-2A8234653437Q39088075-44048F7E-EA1A-49F7-A399-2353C09499A4Q39178399-4D62368A-65FF-4967-A69F-578A17BD44FBQ39197238-D465E6D1-6159-44F7-AE10-85835F7728D2Q39229350-4D3E48EE-0BDD-4847-8562-71B36AF8F9CEQ39249384-F982A471-B6C8-4033-B062-CE0937F273D9Q39365490-71135711-1CFF-4E4C-BEF9-43643F9E8F27Q40104157-A2ADD237-2D04-47D2-AF70-23D94011B626Q40140858-0637ACBB-4287-45C6-9A36-EE4E861D0B13Q40245763-2991A03D-2D30-4660-9E2F-95E3A9B21783Q40403661-EB4474A6-82B6-4B81-ACFF-3FBF62EFA8B3Q40527658-33441DAD-BFDA-4577-B1F0-049DAE174A0FQ40971881-461A2490-3E9A-462C-9AD7-7D78A69BAAD4Q41230578-3C11E4D9-BB45-4CA7-AE8A-61E71AC9D2EAQ41479135-2467D228-267B-4DDA-947B-60B9C756811FQ41609633-F4870035-9779-4347-8FDF-DB019EE8DB9AQ41997642-5447BF76-1BC4-4E14-BD11-CA26416FD954Q42368319-7B6A8314-97BE-471C-81D3-8A9A138B8811Q46380449-1D48A045-E75B-4B3E-BF6A-AEE2BA87C3F3Q47102661-31424287-26D0-4FDE-A366-65A6536C9DD4Q47134033-317AE57F-46F2-4335-8764-D4D3DDE8A9D0Q47225724-19C195F8-69AE-4B6C-8A8C-C3FFE6856D73Q47447868-E4B5CABF-9433-4E84-91DD-3C62400E4A8CQ47831410-650E542F-4C3D-49B6-A81D-723728D303BAQ47893052-BEBA2349-1BE6-402B-8145-1A60AE93EA03Q47979606-FE8BAF8B-F999-4537-BDBB-86700CB71BB2
P2860
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Resolution of inflammation: a new therapeutic frontier.
@en
type
label
Resolution of inflammation: a new therapeutic frontier.
@en
prefLabel
Resolution of inflammation: a new therapeutic frontier.
@en
P356
P1476
Resolution of inflammation: a new therapeutic frontier.
@en
P2888
P304
P356
10.1038/NRD.2016.39
P577
2016-03-29T00:00:00Z